-
(First published on 20 March 2019; updated on 24 March 2020, 23 March 2021, 23 March 2022 on the Cochrane Library, and updated 7 November 2022 on the CIDG website)Tuberculosis continues to cause great suffering worldwide. It is expected that once the data are compiled, tuberculosis will rank second as a cause of death from a single...
November 2 2022
-
During October 2022, the CIDG published one updated review, in Issue 10 2022 of the Cochrane Database of Systematic Reviews. Further details are below.Updated review Fox T, Furnival-Adams J, Chaplin M, Napier M, Olanga EA. House modifications for preventing malaria. Cochrane Database of Systematic Reviews 2022, Issue 10. Art. No.:...
October 31 2022
-
Installing mosquito screening over house windows and closing the gaps in house eaves can help reduce infection with Plasmodium parasites and the number of people with anaemia in the household, according to an updated Cochrane Review published this week. Householders can implement many of these house modifications themselves, providing a...
October 6 2022
-
During September 2022, the CIDG published one new protocol, one new review, and two review updates in Issue 9, 2022 of the Cochrane Database of Systematic Reviews. New ProtocolPérez-Gaxiola G, Velásquez-Salazar P, Veroniki AA, Zambrano-Rico S, Hernández Alcaraz M, Cuello-García CA, Florez ID. Interventions for treating head lice: a...
October 5 2022
-
Is the combination nirmatrelvir plus ritonavir effective for treating or preventing COVID‐19?Key messagesNirmatrelvir/ritonavir (Paxlovid®) is evaluated for the treatment of coronavirus disease 2019 (COVID‐19).Nirmatrelvir/ritonavir may lead to fewer deaths and improve patient condition, as assessed by need for hospitalization or death within 28...
September 20 2022
-
This year the Cochrane Database of Systematic Reviews (CDSR) Journal Impact Factor is 12.008; this is an increase on the 2020 Journal Impact Factor which was 9.289. In addition, our (unofficial) CIDG impact factor is 34.275 (40 publications cited 1371 times). This is great news for the CIDG and justifies our strategy...
September 14 2022
-
This leadership role is for a highly experienced scientist in evidence synthesis who will lead the further development of evidence synthesis, as part of the Global Health Trials and Synthesis Unit, and across the Liverpool School of Tropical Medicine and its partners. The Department of Clinical Sciences is a global leader in evidence...
September 13 2022
-
With experience as a doctor in the UK NHS and in Papua New Guinea, former Cochrane Infectious Diseases Group (CIDG) Coordinating Editor Professor Paul Garner was part of the team that set up Cochrane. Cochrane successfully mainstreamed systematic reviews globally as a method and has been highly influential in institutionalising their use in formal...
September 13 2022
-
Key messages• In regions where malaria is a serious problem (malaria‐endemic areas), many people cannot access the treatment they need.• Rapid diagnostic tests for diagnosing malaria (mRDTs) are simple to use: they involve dropping a finger prick of blood onto a small cassette. • In the context of community‐based programmes in malaria‐endemic...
September 13 2022
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in childrenWhy is improving the diagnosis of tuberculosis important?Every year, an estimated one million children and young adolescents become ill with tuberculosis, and around 226,000 die from the disease. Tuberculosis is caused by the bacterium Mycobacterium...
September 7 2022